A prospective study on the efficacy of sequential treatment of technology Lipido-Colloid Impregnated with Silver and Technology Lipido-Colloid Nano-Oligosaccharide Factor in the management of venous leg ulcers.

Health Sci Rep · 2023 · PMC10447879 · PMID 37636288

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

34 , 35 A multicenter RCT of 187 patients comparing 2–4LB reported more significant reduction in pain over time between dressing changes when 2LB was used compared to 4LB, although this did not reach statistical significance. 36 Our study is unable to validate this study as this is a single‐arm study assessing the efficacy and safety of pilot sequential therapy.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.